Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Immunological Memory

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

In vivo cytokine adsorption reveals distinct neutrophil mobilization pathways during experimental human endotoxemia.

Journal of innate immunity·2026

Same author

Glucocorticoid-driven gene expression in circulating monocytes and neutrophils in health and severe inflammation.

Journal of leukocyte biology·2026

Same author

High interobserver reliability of neutrophil phenotyping based on visual determination of CD16/CD62L expression patterns.

Langenbeck's archives of surgery·2026

Same author

Publisher Correction: Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026.

Intensive care medicine·2026

Same author

Letter to the editor - Early post lung transplant neutrophil dynamics within 72 h.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026

Same author

Innovation in intensive care: a framework to turn ideas and concepts into actionable solutions.

Intensive care medicine·2026

Same journal

The evolution of nonoperating room anesthesia: navigating a new frontier.

Current opinion in anaesthesiology·2026

Same journal

Enhanced recovery pathways for patients with chronic pain: beyond standard protocols - a narrative review.

Current opinion in anaesthesiology·2026

Same journal

Novel technologies and innovations in postoperative follow-up after regional anesthesia.

Current opinion in anaesthesiology·2026

Same journal

Regional anaesthesia and analgesia in surgical patients with chronic preoperative pain: mechanisms, evidence, and clinical implications.

Current opinion in anaesthesiology·2026

Same journal

Retention in pain care and research: a narrative review focused on implanted medical devices.

Current opinion in anaesthesiology·2026

Same journal

Airway ultrasound in patients undergoing head and neck surgery.

Current opinion in anaesthesiology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Immunotherapy after trauma: timing is essential.

Kathelijne M Groeneveld¹, Luke P H Leenen, Leo Koenderman

¹Department of Surgery, University Medical Centre Utrecht, Utrecht, The Netherlands. k.m.groeneveld@umcutrecht.nl

Current Opinion in Anaesthesiology

|February 5, 2011

Summary

This summary is machine-generated.

Immunomodulating therapies aim to manage the inflammatory response after trauma. Despite extensive research, few interventions have translated into clinical practice, highlighting the need for better understanding of trauma-induced inflammation.

More Related Videos

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

Related Experiment Videos

Last Updated: Jun 4, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors

Published on: June 7, 2018

Area of Science:

Trauma and Injury
Immunology
Critical Care Medicine

Background:

Systemic inflammation following trauma is a complex, heterogeneous process.
Numerous immunomodulatory agents have been investigated to mitigate inflammatory complications.
Clinical translation of experimental therapies remains limited.

Purpose of the Study:

To review key issues and recent insights in immunomodulating interventions for trauma patients.
To summarize the current landscape of therapies targeting post-traumatic inflammation.
To identify gaps in understanding and application of immunomodulation in trauma care.

Main Methods:

Literature review of immunomodulating interventions in trauma.
Analysis of experimental and clinical studies on anti-inflammatory therapies.
Synthesis of evidence regarding efficacy and clinical utility.

Main Results:

A wide array of immunomodulatory agents (e.g., monoclonal antibodies, antiendotoxins, antioxidants) have been tested.
Recent clinical intervention studies in this area have become infrequent.
Most promising experimental approaches have not altered clinical practice for managing inflammatory complications.

Conclusions:

Deeper understanding of the pathology of systemic inflammation post-trauma is crucial.
Improved patient selection, optimal therapeutic timing, and mechanism-based treatments are needed.
Further research is required to effectively address the underlying mechanisms of inflammatory complications.